ArticleLeukemia research2012

Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML.

Rajesh R Nair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.